Tag: Pharma news today
New Meta-Analysis Ranks CAPLYTA®️ Lumateperone First in Efficacy and Metabolic Safety for Adjunctive MDD Treatment
Intra-Cellular Therapies, Inc. announced the presentation of a new network meta-analysis (NMA) demonstrating that CAPLYTA® (lumateperone) showed the greatest improvement across four key efficacy outcomes among...
Intervein Clears USFDA Inspection, Strengthens Global Standards in IVRT & IVPT
Intervein Research Labs Pvt. Ltd. has successfully completed a recent inspection by the U.S. Food and Drug Administration, marking a key milestone in its regulatory...